ProShares Ultra Nasdaq Biotechnology (BIB): Price and Financial Metrics ETF
BIB Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $50.09 | 52-week high | $62.45 |
| Prev. close | $50.33 | 52-week low | $40.10 |
| Day low | $49.91 | Volume | 11,030 |
| Day high | $50.90 | Avg. volume | 38,983 |
| 50-day MA | $55.61 | Dividend yield | 0.15% |
| 200-day MA | $52.03 |
BIB Stock Price Chart Interactive Chart >
ProShares Ultra Nasdaq Biotechnology (BIB) ETF Bio
The investment objective of the ProShares Ultra Nasdaq Biotechnology ETF seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index.
BIB ETF Info
| Issuer | ProShares |
| Expense Ratio | 0.95% |
| Underlying Index | NASDAQ Biotechnology Index |
| Asset Class | Equity |
| Sector | Leveraged Equities ETFs |
| Assets Under Management (AUM) | 82.04M |
| Net Asset Value (NAV) | $50.33 |
| Options? | Yes |
| Total Holdings | 230 |
BIB Top Holdings
| Symbol | Company | % of Total |
| BIB | ProShares Ultra Nasdaq Biotechnology ETF | 0% |
| AMGN | AMGEN INC | 0% |
BIB Price Returns
| 1-mo | -11.14% |
| 3-mo | -13.59% |
| 6-mo | 24.31% |
| 1-year | -10.30% |
| 3-year | -43.58% |
| 5-year | -1.23% |
| YTD | -12.14% |
| 2023 | -1.06% |
| 2022 | -28.85% |
| 2021 | -6.02% |
| 2020 | 39.79% |
| 2019 | 46.71% |
BIB Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||